Kakao VX seeks to raise $90 mln Three financial investors in talks with subsidiary of Kakao Games
Translated by Kim So-in 공개 2021-06-14 07:40:55
이 기사는 2021년 06월 14일 07:37 thebell 에 표출된 기사입니다.
Kakao VX, a subsidiary of Kakao Games, seeks to raise 100 billion won ($90 million) from outside investors to expand its new business.Kakao VX is in talks with three financial investors for its planned fundraising, industry sources said Thursday.
This will be the company’s third fundraising, aiming to expand its business to other golfing segments.
Kakao VX raised a combined 8 billion won from KB Securities, Mirae Asset Daewoo, Korea Investment Partners and BTC Investment through a rights offering in 2018. The firm raised 20 billion won from Q Capital in 2019. Q Capital acquired redeemable convertible preference shares (RCPS) of Kakao VX using its fund closed at 300 billion won.
Kakao VX reportedly plans to select one of the three financial investors, which values the company the highest on a pre-money basis.
Kakao VX entered the screen golf market in 2017 by purchasing Maum Golf, the second largest screen golf operator. Kakao adapted Kakao Friends’ popular characters to its screen golf system to increase its market share with young golfers.
Apart from screen golf, it has smart home training, a golf booking service through an artificial intelligence-based chatbot, and golf product businesses.
The company is also very active in golf course acquisitions and consignment operations. Kakao VX signed consignment agreements in 2019 with Gyeongnam Tourist Hotel and Hamyang Sky View Golf Club, an 18-hole public golf course.
Earlier this year, a consortium of Kakao VX and Stonebridge Asset Management was picked as the preferred bidder for Ceragio Country Club (CC) in Yeoju, Gyeonggi Province and Saint Four CC in Jeju Island, which are owned by Halla Group. (Reporting by Seon-young Kim)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- 시노펙스, 혈액투석필터 5개 상급병원 임상 돌입
- 한컴, 선택과 집중 전략으로 포트폴리오 재편
- 우리기술, 정부SMR개발 참여 'AI 전력수요 대응'
- [biotech with revenue]돈 못버는 오가노이드? 엠비디 승부수 환자 대상 '튜머로이드'
- 싸이토젠, '법차손' 자신감 배경 '매출'…특허 확장 총력
- [thebell interview]이선규 마티니 대표 “기업과 시너지 내는 마케팅의 진수”
- [제주반도체 재도약의 시간]소액주주 비중 절대적 '불안정한 지배구조'
- [thebell interview]"제네시스랩, 신뢰성 바탕으로 대면면접 시장 공략"
- [동아-일동 'R&D 협업' 승부수]일동제약, 신약으로 낸 첫 성과 "아직 더 보여줄 게 있다"
- BNH인베 첫 단독 블라인드펀드, 성과보수 '가시권'